Chemo-immunotherapy - the role of monoclonal antibodies for the treatment of chronic lymphocytic leukemia (CLL)

被引：0
|
作者：
Hallek, M [1 ]
Wendtner, CM [1 ]
Fingerle-Rowson, G [1 ]
Fischer, K [1 ]
Goede, V [1 ]
Schweighofer, C [1 ]
Fink, AM [1 ]
Elter, T [1 ]
Kofler, D [1 ]
Busch, R [1 ]
Emmerich, B [1 ]
Eichhorst, B [1 ]
机构：
[1] Univ Cologne, GCLLSG, Innere Med Klin 1, Cologne, Germany
来源：
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 2005年 / 55卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：704 / 705
页数：2
相关论文
共 50 条
  • [1] Immunomodulatory Effects of Chemo-Immunotherapy ± Idelalisib in Chronic Lymphocytic Leukaemia (CLL)
    Lim, Yeong Jer
    Duckworth, Andrew
    Clarke, Kim
    Oates, Melanie
    Gornall, Matthew
    Kalakonda, Nagesh
    Slupsky, Joseph
    Pettitt, Andrew
    [J]. BLOOD, 2023, 142
  • [2] Salvage therapy following failure or relapse after FCR chemo-immunotherapy as initial treatment for chronic lymphocytic leukemia (CLL)
    Keating, M. J.
    Wierda, W.
    O'Brien, S.
    Tam, C.
    Lerner, S.
    Kantarjian, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Passe Yet?
    Danilov, Alexey, V
    Pagel, John M.
    Brown, Jennifer R.
    Hill, Brian T.
    [J]. HEMASPHERE, 2019, 3 (04):
  • [4] Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Time to Retire?
    Scarfo, Lydia
    Tedeschi, Alessandra
    [J]. HEMASPHERE, 2019, 3 (04):
  • [5] Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia
    Kharfan-Dabaja, Mohamed A.
    Fahed, Rabih
    Hussein, Mohamad
    Santos, Edgardo S.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (11) : 1799 - 1815
  • [6] Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
    Liu, NS
    O'Brien, S
    [J]. MEDICAL ONCOLOGY, 2004, 21 (04) : 297 - 304
  • [7] Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
    Nina Shih Liu
    Susan O’Brien
    [J]. Medical Oncology, 2004, 21 : 297 - 304
  • [8] Impact of ibrutinib or FCR chemo-immunotherapy on the B lymphocyte repertoire in chronic lymphocytic leukemia
    Schliffke, S.
    Sivina, M.
    Kim, E.
    von Wenserski, L.
    Thiele, B.
    Akyuez, N.
    Falker-Gieske, C.
    Statovci, D.
    Oberle, A.
    Thenhausen, T.
    Krohn-Grimberghe, A.
    Bokemeyer, C.
    Jain, N.
    Estrov, Z.
    Ferrajoli, A.
    Wierda, W.
    Keating, M.
    Burger, J.
    Binder, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 26 - 26
  • [9] Chemo-immunotherapy improve the survival of patients with chronic lymphocytic leukemia chemistry (CLL) - a metaanalysis of five studies fo the German CLL study group (DCLLSG)
    Cramer, P.
    Isfort, S.
    Bahlo, J.
    Busch, R.
    Langerbeins, P.
    Fink, A.
    Goede, V.
    Elter, T.
    Bergmann, M.
    Stauch, M.
    Stilgenbauer, S.
    Wendtner, C.
    Fischer, K.
    Hallek, M.
    Eichhorst, B.
    [J]. INTERNIST, 2013, 54 : 37 - 37
  • [10] Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia
    Robak, Tadeusz
    [J]. CURRENT CANCER DRUG TARGETS, 2008, 8 (02) : 156 - 171
12345